Objective: To summarize key changes in the 2007 American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations for pharmacologic therapy as they relate to antiplatelets ...
PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended ...
Bethesda, MD and Dallas, TX - The American College of Cardiology (ACC) and the American Heart Association (AHA) have updated practice guidelines to hone the management of patients with unstable angina ...
When a patient presents with chest pain, follow this doctor’s guidelines to quickly reach an accurate diagnosis and initiate life-saving treatment. For some time, cardiologists have called MIs and ...
Test your knowledge of Coronary Artery Disease - Unstable Angina/Non-STEMI with this ready-made quiz. Which of the following approaches to medical therapy is appropriate during unstable angina or ...
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised “Guidelines on the Management ...
A non-ST segment elevation myocardial infarction, also called an NSTEMI or a non-STEMI, is a type of heart attack. While it's often less damaging to your heart than a STEMI, it's still a serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results